Table 1. IMI's fourth call. The fourth set of projects launched by the Innovative Medicines Initiative (IMI) comprise seven projects that are a joint effort of the European Commission and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The below projects include each program's expected contributions from the EFPIA and IMI. In total, the projects have a combined budget from the IMI and the EFPIA of €237 million ($313 million).



Contribution (million)

Project title

EFPIA participantsA

EFPIA in kind


CHEM21 (Chemical Manufacturing Methods for the 21st Century Pharmaceutical Industries)

GlaxoSmithKline plc (LSE:GSK; NYSE:GSK); Bayer AG (Xetra:BAYN); Johnson & Johnson (NYSE:JNJ); Orion Corp. (HSE:ORNAV; HSE:ORNBV); Pfizer Inc. (NYSE:PFE); Sanofi (Euronext:SAN; NYSE:SNY)

€9.8 ($13.0)

€13.6 ($18)

COMPACT (Collaboration on the Optimization of Macromolecular Pharmaceutical Access to Cellular Targets)

Sanofi; Boehringer Ingelheim GmbH; Bayer; Johnson & Johnson; GlaxoSmithKline; Merck KGaA (Xetra:MRK); Novo Nordisk A/S (CSE:NVO; NYSE:NVO); Pfizer

€10.2 ($13.5)

€16.6 ($22)

EMIF (European Medical Information Framework)

GlaxoSmithKline; Amgen Inc. (NASDAQ:AMGN); Boehringer Ingelheim; Roche (SIX:ROG; OTCQX:RHHBY); Johnson & Johnson; Novo Nordisk; Pfizer; Servier; UCB Group (Euronext:UCB)

€24.4 ($32.3)

€24.1 ($31.9)

eTRIKS (delivering European Translational Information and Knowledge Management Services)

AstraZeneca plc (LSE:AZN; NYSE:AZN); Bayer; Eli Lilly and Co. (NYSE:LLY); Roche; GlaxoSmithKline; H. Lundbeck A/S (CSE:LUN); Johnson & Johnson; Merck KGaA; Pfizer; Sanofi

€10.3 ($13.6)

€10.3 ($13.6)

K4DD (Kinetics for Drug Discovery)

Bayer; AstraZeneca; Roche; GlaxoSmithKline; Johnson & Johnson;
Merck KGaA; Sanofi

€8.3 ($11.0)

€9.8 ($13.0)

ORBITO (Oral Biopharmaceutics Tools)

AstraZeneca; Abbott Laboratories (NYSE:ABT); Bayer; Boehringer Ingelheim; GlaxoSmithKline; H. Lundbeck; Johnson & Johnson;
Merck & Co. Inc. (NYSE:MRK); Novartis AG (NYSE:NVS; SIX:NOVN); Orion; Pfizer; Sanofi

€9 ($11.9)

€11.5 ($15.2)

STEMBANCC (Stem Cells for Biological Assays of Novel Drugs and Predictive Toxicology)

Roche; Abbott; Boehringer Ingelheim; Eli Lilly; Johnson & Johnson; Merck KGaA; Novo Nordisk; Orion; Pfizer; Sanofi

€26 ($34.4)

€21 ($27.8)

 AParent company of participating subsidiaries listed.